Pancreatic Cancer Research

ResearcherTohoku UniversityActive in the last 2 years

Kazuhiro Kikuta

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5071735777, A5135218649. Sources: OpenAlex.

Their work

Papers
15 (first author 3, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
25
Papers, trials and grants by year

2012: 3 papers · 2013: 2 papers · 2014: none · 2015: none · 2016: none · 2017: 2 papers · 2018: none · 2019: none · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 4 papers

Papers 15

  1. Mortality and cancer risk in patients with chronic pancreatitis in japan: insights into the importance of surveillance for pancreatic cancer. First author DOI 10.1007/s00535-025-02321-0↗
  2. Utility of longitudinal changes in CA19-9 for detection of pancreatic ductal adenocarcinoma in patients with benign pancreatic diseases. Co-author DOI 10.1016/j.pan.2026.10.007↗
  3. Type I Collagen Increases Survivin Expression in Pancreatic Cancer Cells. Co-author DOI 10.1620/tjem.2026.j084↗
  4. Diabetes Trajectory and Pancreatic Cancer Detection in Patients with Diabetes: A Nationwide Survey Through Japan Diabetes Society-Certified Facilities. Last author DOI 10.3390/cancers18182995↗
  5. Clinical features and prognostic impact of asymptomatic pancreatic cancer. First author DOI 10.1038/s41598-022-08083-6↗
  6. Focal Parenchymal Atrophy of the Pancreas Is Frequently Observed on Pre-Diagnostic Computed Tomography in Patients with Pancreatic Cancer: A Case-Control Study. Co-author DOI 10.3390/diagnostics11091693↗
  7. New-Onset or Exacerbation of Diabetes Mellitus Is a Clue to the Early Diagnosis of Pancreatic Cancer. First author DOI 10.1620/tjem.252.353↗
  8. Focal Parenchymal Atrophy and Fat Replacement Are Clues for Early Diagnosis of Pancreatic Cancer with Abnormalities of the Main Pancreatic Duct. Co-author DOI 10.1620/tjem.252.63↗
  9. Kindlin-2 in pancreatic stellate cells promotes the progression of pancreatic cancer. Co-author DOI 10.1016/j.canlet.2017.01.008↗
  10. Plasma Kallikrein-Dependent Transforming Growth Factor-β Activation in Patients With Chronic Pancreatitis and Pancreatic Cancer. Co-author DOI 10.1097/mpa.0000000000000736↗
  11. miR-197 induces epithelial-mesenchymal transition in pancreatic cancer cells by targeting p120 catenin. Co-author DOI 10.1002/jcp.24280↗
  12. The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice. Co-author DOI 10.3109/00365521.2013.777776↗
  13. The homeobox gene MSX2 determines chemosensitivity of pancreatic cancer cells via the regulation of transporter gene ABCG2. Co-author DOI 10.1002/jcp.22781↗
  14. Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells. Co-author DOI 10.1016/j.bbrc.2012.04.014↗
  15. MiR-126 acts as a tumor suppressor in pancreatic cancer cells via the regulation of ADAM9. Co-author DOI 10.1158/1541-7786.mcr-11-0272↗

Closest collaborators

The 25 strongest of 25 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Atsushi Masamune · 14 shared papers, 2012–2026 · strength 1.54
  2. Tetsuya Takikawa · 10 shared papers, 2012–2026 · strength 1.38
  3. Ryotaro Matsumoto · 7 shared papers, 2020–2026 · strength 1.24
  4. Shin Hamada · 12 shared papers, 2012–2026 · strength 1.18
  5. Shin Miura · 7 shared papers, 2013–2026 · strength 0.74
  6. Michiaki Unno · 6 shared papers, 2013–2026 · strength 0.66
  7. Naoki Yoshida · 5 shared papers, 2017–2022 · strength 0.51
  8. Tooru Shimosegawa · 7 shared papers, 2012–2017 · strength 0.31
  9. Naoko Hozumi · 1 shared paper, 2026 · strength 0.28
  10. Fumiya Kataoka · 2 shared papers, 2021–2022 · strength 0.25
  11. Shuichi Aoki · 1 shared paper, 2026 · strength 0.23
  12. Toshiaki Abe · 1 shared paper, 2026 · strength 0.23
  13. Masahiro Iseki · 2 shared papers, 2020 · strength 0.19
  14. Kei Nakagawa · 1 shared paper, 2022 · strength 0.13
  15. Kennichi Satoh · 4 shared papers, 2012–2013 · strength 0.12
  16. Fuyuhiko Motoi · 2 shared papers, 2013–2017 · strength 0.10
  17. Toru Furukawa · 1 shared paper, 2020 · strength 0.09
  18. Atsushi Kanno · 3 shared papers, 2012–2013 · strength 0.09
  19. Ryutaro Teraoka · 1 shared paper, 2017 · strength 0.07
  20. Soichi Kojima · 1 shared paper, 2017 · strength 0.07
  21. Yoshiki Hirooka · 1 shared paper, 2017 · strength 0.07
  22. Jun Unno · 2 shared papers, 2012–2013 · strength 0.06
  23. Shinichi Egawa · 1 shared paper, 2013 · strength 0.03
  24. Hiromichi Ito · 1 shared paper, 2012 · strength 0.03
  25. Masayoshi Kobune · 1 shared paper, 2012 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.